ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1442

$987K Total Retail Price of All Prescriptions

Rank: 21 out of 1442

563 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 12,603 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 778 736 1 3
CRESTOR 600 550 2 10
CARVEDILOL 487 437 3 8
METOPROLOL SUCCINATE 458 448 4 1
FUROSEMIDE 392 391 5 5
NEXIUM 315 315 6 34
SIMVASTATIN 295 283 7 2
PLAVIX 252 230 8 14
WARFARIN SODIUM 250 248 9 9
LOSARTAN POTASSIUM 238 235 10 13
ZOLPIDEM TARTRATE 230 223 11 25
HYDROCHLOROTHIAZIDE 204 196 12 16
METOPROLOL TARTRATE 202 187 13 6
ATENOLOL 185 185 14 11
ATORVASTATIN CALCIUM 182 176 15 4
AMLODIPINE BESYLATE-BENAZEPRIL 181 174 16 43
CLOPIDOGREL 180 161 17 12
RAMIPRIL 180 174 17 18
DIOVAN 171 163 19 19
TAMSULOSIN HCL 152 146 20 38
SYNTHROID 148 148 21 40
LIPITOR 147 147 22 24
PRAVASTATIN SODIUM 128 128 23 20
METFORMIN HCL 126 114 24 26
QUINAPRIL HCL 112 108 25 42
GLIMEPIRIDE 111 106 26 67
LISINOPRIL 111 94 26 7
DIGOXIN 110 109 28 15
LEVOTHYROXINE SODIUM 109 107 29 22
BYSTOLIC 106 105 30 32
ACTOS 103 101 31 110
COREG CR 98 97 32 96
ESCITALOPRAM OXALATE 98 93 32 150
LOVAZA 96 85 34 37
EXFORGE 95 95 35 80
PANTOPRAZOLE SODIUM 95 76 35 63
DOXAZOSIN MESYLATE 93 93 37 69
METFORMIN HCL ER 91 83 38 71
ISOSORBIDE MONONITRATE ER 84 83 39 17
FINASTERIDE 84 84 39 87
OMEPRAZOLE 84 80 39 21
LOSARTAN-HYDROCHLOROTHIAZIDE 84 84 39 30
JANUVIA 82 82 43 45
POTASSIUM CHLORIDE 82 80 43 33
BENICAR 79 79 45 61
CLONIDINE HCL 79 63 45 66
COUMADIN 77 77 47 41
ADVAIR DISKUS 74 74 48 79
DONEPEZIL HCL 74 74 48 62
NIFEDIPINE ER 68 65 50 39
DIOVAN HCT 66 66 51 35
RANITIDINE HCL 64 64 52 64
TRICOR 61 55 53 100
SINGULAIR 61 58 53 93
LEXAPRO 60 60 55 211
PROAIR HFA 59 55 56 123
SPIRIVA 59 59 56 95
ALENDRONATE SODIUM 58 58 58 46
LOVASTATIN 58 58 58 53
CELEBREX 56 51 60 138
ALLOPURINOL 56 55 60 47
FAMOTIDINE 55 51 62 70
TRAMADOL HCL-ACETAMINOPHEN 55 55 62 170
AVODART 55 55 62 145
ZETIA 54 50 65 31
CITALOPRAM HBR 54 54 65 81
PRADAXA 53 53 67 27
DILTIAZEM 24HR CD 50 50 68 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.